Antivirals: Difference between revisions
ClaireLewis (talk | contribs) (→HAART) |
ClaireLewis (talk | contribs) |
||
| Line 5: | Line 5: | ||
*[[Ganciclovir]] | *[[Ganciclovir]] | ||
*[[Valacyclovir]] | *[[Valacyclovir]] | ||
*[[Valganciclovir]] | |||
==Anti-influenza agents== | ==Anti-influenza agents== | ||
Revision as of 01:23, 26 February 2017
Anti-herpetic agents
Anti-influenza agents
Adamantane Derivatives
Neuraminidase Inhibitors
Interferons
HAART
- HIV regimen that typically consists of combination of 2 nucleoside and/or non-nucleoside reverse transcriptase inhibitors PLUS a protease inhibitor, reverse-transcriptase inhibitor, or integrase inhibitor
- US DHHS first-line regimens
- Emtricitabine/tenofovir (Truvada) + raltegravir
- Emtricitabine/tenofovir + dolutegravir
- Abacavir/lamivudine( (Epzicom) + dolutegravir OR abacavir/lamivudine/dolutegravir (Triumeq)
- Emtricitabine/tenofovir/elvitegravir/cobicistat (Stribild)
- Emtricitabine/tenofovir + ritonavir + darunavir
- WHO first-line regimen
- Emtricitabine/tenofovir/efavirenz (Atripla)
- Tenofovir + lamivudine + efavirenz